Raymond James Trust N.A. Teva Pharmaceutical Industries LTD Transaction History
Raymond James Trust N.A.
- $4.55 Billion
- Q3 2024
A detailed history of Raymond James Trust N.A. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Raymond James Trust N.A. holds 10,434 shares of TEVA stock, worth $204,610. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,434
Previous 10,827
3.63%
Holding current value
$204,610
Previous $175,000
7.43%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding TEVA
# of Institutions
659Shares Held
659MCall Options Held
30.1MPut Options Held
16.4M-
Black Rock Inc. New York, NY43MShares$843 Million0.02% of portfolio
-
Menora Mivtachim Holdings Ltd.38.5MShares$755 Million3.78% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E938.3MShares$752 Million36.86% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L337.8MShares$741 Million5.98% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L337.8MShares$741 Million8.62% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $21.8B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...